Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-09 4:02 pm Sale |
2022-07-31 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
4,991,287 5.300% |
-5,236,386 (-51.20%) |
Filing History |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
10,227,673 10.900% |
2,209,039 (+27.55%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 5.100% |
-3,000,000 (-38.32%) |
Filing History |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 7,554,042 8.250% |
1,366,337 (+22.08%) |
Filing History |
| 2022-02-09 10:56 am Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
4,608,758 5.000% |
-1,306,776 (-22.09%) |
Filing History |
| 2022-02-09 09:07 am Sale |
2022-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,278,807 13.594% |
-467,707 (-3.40%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
8,018,634 8.800% |
2,855,614 (+55.31%) |
Filing History |
| 2022-01-18 06:57 am Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 6,878,377 7.510% |
6,878,377 (New Position) |
Filing History |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,746,514 14.059% |
-2,915,302 (-17.50%) |
Filing History |
| 2021-07-30 5:04 pm Sale |
2021-07-01 | 13D | 10x Genomics, Inc. TXG |
Hindson Benjamin J. | 3,611,410 4.000% |
-438,590 (-10.83%) |
Filing History |
| 2021-07-30 5:01 pm Purchase |
2021-07-06 | 13D | 10x Genomics, Inc. TXG |
Saxonov Serge | 4,851,530 5.300% |
123,879 (+2.62%) |
Filing History |
| 2021-02-16 4:17 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Meritech Capital Partners V L.P. | 2,580,975 3.200% |
-1,079,979 (-29.50%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 7,828,247 9.100% |
-3,263,569 (-29.42%) |
Filing History |
| 2021-02-16 10:34 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Foresite Capital Fund I L.P. | 3,753,528 4.700% |
-10,319,121 (-73.33%) |
Filing History |
| 2021-02-16 09:11 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
SB INVESTMENT ADVISERS (UK) LTD | 0 0.000% |
-3,836,232 (Position Closed) |
Filing History |
| 2021-02-11 6:37 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Paladin Capital Management LLC | 2,165,199 2.700% |
-6,509,968 (-75.04%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 6,187,705 7.720% |
6,187,705 (New Position) |
Filing History |
| 2021-02-10 10:23 am Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
5,915,534 7.400% |
-877,284 (-12.91%) |
Filing History |
| 2021-02-08 10:13 am Purchase |
2021-02-05 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 16,661,816 19.207% |
4,520,624 (+37.23%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
BLACKROCK INC BLK |
5,163,020 6.400% |
5,163,020 (New Position) |
Filing History |